SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-19-000187
Filing Date
2019-06-17
Accepted
2019-06-17 12:31:39
Documents
9
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6K avricore6kjuly18-19.htm 6-K 8572
2 NEWS RELEASE ex99-1.htm EX-99 6420
3 NEWS RELEASE ex99-2.htm EX-99 6675
4 MATERIAL CHANGE REPORT ex99-3.htm EX-99 7745
5 NOTICE OF SHAREHOLDER MEETING ex99-4.htm EX-99 541
6 ex9911.jpg GRAPHIC 22379
7 ex9941.jpg GRAPHIC 148694
8 ex9921.jpg GRAPHIC 38082
9 ex9922.jpg GRAPHIC 4163
  Complete submission text file 0001052918-19-000187.txt   325452
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 19900894
SIC: 2834 Pharmaceutical Preparations